baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

UC BON.CAP.CERT. 06/24 LLY/ DE000HD3T9V6 /

2024-05-20 9:47:00 PM	Chg.-0.100	Bid2024-05-20	Ask-	Underlying	Strike price	Expiration date	Option type
1,299.800EUR	-0.01%	1,299.800 Bid Size: 110	- Ask Size: -	ELI LILLY	- -	2024-06-28	Call

GlobeNewswire 05-16 BeyondSpring R&D Day Highlights New Plinabulin Development Strategy for Cancer and Updates for SEED ...

GlobeNewswire 05-16 Totus Medicines Announces Strategic Multi-Target Research Collaboration with Lilly

GlobeNewswire 05-16 HEPHAISTOS secures €10.3 M to reach the clinical stage

GlobeNewswire 05-15 Entera Bio Appoints Dr. Rachel B Wagman as Key Clinical Advisor and Scientific Advisory Board Member

GlobeNewswire 05-13 Lycia Therapeutics Completes $106.6 Million Series C Financing to Advance Pipeline of LYTAC Extracel...

GlobeNewswire 05-09 US Neurologists Report Route of Administration as a Critical Factor when Evaluating Future Parkinson...

GlobeNewswire 05-09 Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...

GlobeNewswire 05-09 ProQR Announces First Quarter 2024 Operating and Financial Results

GlobeNewswire 05-08 Merus Announces Financial Results for the First Quarter 2024 and Provides Business Update

GlobeNewswire 05-08 Therini Bio Announces Positive Preclinical Data Supporting the Development of THN391 in Neurodegener...

GlobeNewswire 05-08 IMUNON Appoints Director Dr. Stacy R. Lindborg as President and CEO

GlobeNewswire 05-08 ProQR Announces Preclinical Proof of Concept Data for AX-0810 Axiomer™ RNA Editing Program Targeting...

GlobeNewswire 05-08 Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results

GlobeNewswire 05-03 BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and U...

GlobeNewswire 05-01 H1 Appoints Seasoned Marketing & Technology Executive Karen Walker to Its Board of Directors

GlobeNewswire 04-30 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors

TeleTrader 04-30 Eli Lilly's Q1 revenue surges 26% to $8.8B

GlobeNewswire 04-30 ViaNautis Bio appoints Dr Steven M. Altschuler as Chairman of its Board of Directors

GlobeNewswire 04-29 BeyondSpring Provides Business Update and Reports Year End 2023 Financial Results

GlobeNewswire 04-29 BeyondSpring Files 2023 Annual Report on Form 20-F

GlobeNewswire 04-29 Sermonix Pharmaceuticals Announces ‘Menopause’ Journal Publication of Article on Oral Lasofoxifene’s...

GlobeNewswire 04-26 HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorecta...

GlobeNewswire 04-25 American Kidney Fund Launches National Kidney Health Equity Media Campaign

GlobeNewswire 04-23 Recludix Pharma Announces the Appointment of Dr. Ajay Nirula, Accomplished Pharma Executive and Immu...

GlobeNewswire 04-22 ProQR Highlights Upcoming Presentations on Axiomer™ RNA Editing at ASGCT 27th Annual Meeting

UC BON.CAP.CERT. 06/24 LLY/ DE000HD3T9V6 /

If you wish to receive reply to your feedback, please provide your email address.